Clover Health Investments (CLOV) Revenue (2019 - 2025)

Clover Health Investments has reported Revenue for 7 years, with the latest figure at $1.9 billion in FY2025.

• For the quarter ending Q1 2026, Revenue rose 60.96% year-over-year to $744.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 48.29% YoY), and the FY2025 full-year result was $1.9 billion, up 37.97% from the prior year.
• Revenue for FY2025 stood at $1.9 billion, up from $1.4 billion in the prior year.
• The five-year high for Revenue was $1.9 billion in FY2025, with the low at $1.1 billion in FY2022.
• Historically, Revenue has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2024.
• Annual changes were most pronounced in 2021 — Revenue soared 121.12% — and 2022, when it decreased 26.3%.
• Clover Health Investments' Revenue stood at $1.5 billion in 2021, then slipped by 26.3% to $1.1 billion in 2022, then rose by 16.19% to $1.3 billion in 2023, then rose by 8.77% to $1.4 billion in 2024, then surged by 37.97% to $1.9 billion in 2025.
• The last three Revenue figures came in at $1.9 billion (FY2025), $1.4 billion (FY2024), and $1.3 billion (FY2023), per Business Quant data.